To explore the expression and potential clinical significance of UBE2S, UBE2C, and Numb in breast cancer, first we analyzed the Oncomine microarray datasets to determine the mRNA levels of UBE2S, UBE2C, and Numb in a variety of malignant tumor types, including breast cancer. Here, NUMB is linked to breast cancer.